Production of viral vaccines for veterinary use

被引:3
|
作者
van Gelder, Pieter [1 ]
Makoschey, Birgit [1 ]
机构
[1] Intervet Int Bv, MSD Anim Hlth, NL-5830 AA Boxmeer, Netherlands
来源
关键词
virus; vaccine; manufacturing; quality; RESPIRATORY SYNCYTIAL VIRUS; MOUTH-DISEASE VACCINES; EMULSION ADJUVANTS; ALUMINUM-HYDROXIDE; INFLUENZA-VIRUS; FEVER VIRUS; ANTIGEN; IMMUNOGENICITY; VACCINATION; ANTIBODIES;
D O I
10.2376/0005-9366-125-103
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
This review provides inside information on the production of vaccines for veterinary use, The vaccines against rinderpest as well as foot and mouth disease are considered milestones in the history of veterinary vaccine production. Modern vaccines are based on the scientific progress in virology, cell biology and immunology. While naturally occurring attenuated viruses or viruses obtained after passage in different animal species or cell culture were used as vaccine strains in the early vaccines, nowadays targeted mutagenesis can be applied to generate vaccine virus strains. In principle, the antigen production process is the same for live and inactivated vaccines. The vaccine virus is usually grown in cell culture, either in roller bottles or bioreactors. Most live vaccines are freeze-dried in order to enable storage in the refridgerator for a longer period. To this end, a so-called stabilizer is added to the culture medium. The inactivation of the vaccine virus for the production of killed vaccines is done by physical or chemical treatments that lead to denaturation of the proteins or damage of the nucleic acids. The inactivated antigen may be further purified and mixed with an adjuvant. The quality standards for vaccines are layed down in international regulations and laws. Numerous tests are performed during the different production steps and on the final product in order to warrant the quality of each batch.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 50 条
  • [1] Recombinant viral vector vaccines for the veterinary use
    Yokoyama, N
    Maeda, K
    Mikami, T
    [J]. JOURNAL OF VETERINARY MEDICAL SCIENCE, 1997, 59 (05): : 311 - 322
  • [2] THE USE OF NEW BIOTECHNICS IN THE PRODUCTION OF VETERINARY VACCINES
    DESMETTRE, P
    [J]. BULLETIN DE L ACADEMIE VETERINAIRE DE FRANCE, 1987, 60 (03): : 293 - 303
  • [3] Potency control of modified live viral vaccines for veterinary use
    Terpstra, C
    Kroese, AH
    [J]. VACCINE, 1996, 14 (01) : 13 - 18
  • [4] Viral vectors for veterinary vaccines
    Sheppard, M
    [J]. ADVANCES IN VETERINARY MEDICINE, VOL 41: VETERINARY VACCINES AND DIAGNOSTICS, 1999, 41 : 145 - 161
  • [5] PRODUCTION OF VETERINARY VACCINES
    SCHRAUWEN, PP
    [J]. ANTONIE VAN LEEUWENHOEK JOURNAL OF MICROBIOLOGY, 1983, 49 (01): : 94 - 95
  • [6] VETERINARY VIRAL VACCINES IN TROPICAL AFRICA
    PROVOST, A
    [J]. ANNALES DE MICROBIOLOGIE, 1982, A133 (03): : 490 - 491
  • [7] Production of veterinary vaccines in the Sudan
    Babiker, SH
    [J]. BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 1996, 109 (01): : 8 - 9
  • [8] Testing for viral contaminants of veterinary vaccines in Hungary
    Kulcsar, Gabor
    Farsang, Attila
    Soos, T.
    [J]. BIOLOGICALS, 2010, 38 (03) : 346 - 349
  • [9] DNA vaccines in veterinary use
    Redding, Laurel
    Weiner, David B.
    [J]. EXPERT REVIEW OF VACCINES, 2009, 8 (09) : 1251 - 1276
  • [10] RABIES VACCINES FOR VETERINARY USE
    CROGHAN, DL
    [J]. JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1970, 156 (12) : 1798 - &